Evidence map›Paper›PMID 25546457›Full record

ArticlePloS one2014

The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation.

Marco Consiglio, Michele Destefanis, Deborah Morena, Valentina Foglizzo, Mattia Forneris, Gianpiero Pescarmona, Francesca Silvagno

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of Vitamin DNutrients · 2019
    Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Supplementation with Vitamin DInternational journal of molecular sciences · 2023
    Article
  13. Review
  14. Vitamin D regulation of energy metabolism in cancer.British journal of pharmacology · 2022
    Review
  15. The Role of Vitamin D in Supporting Health in the COVID-19 Era.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Mitochondrial potassium channels: A novel calcitriol target.Cellular & molecular biology letters · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Marco ConsiglioDepartment of Oncology, University of Torino, Torino, Italy.
Michele DestefanisDepartment of Oncology, University of Torino, Torino, Italy.
Deborah MorenaDepartment of Oncology, University of Torino, Torino, Italy; Center for Experimental Research and Medical Studies, S. Giovanni Battista Hospital, Torino, Italy.
Valentina FoglizzoDepartment of Oncology, University of Torino, Torino, Italy; Center for Experimental Research and Medical Studies, S. Giovanni Battista Hospital, Torino, Italy.
Mattia FornerisDepartment of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Italy.
Gianpiero PescarmonaDepartment of Oncology, University of Torino, Torino, Italy.
Francesca SilvagnoDepartment of Oncology, University of Torino, Torino, Italy.
University of Turin · ITAzienda Ospedaliero Universitaria San Giovanni Battista · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We recently described the mitochondrial localization and import of the vitamin D receptor (VDR) in actively proliferating HaCaT cells for the first time, but its role in the organelle remains unknown. Many metabolic intermediates that support cell growth are provided by the mitochondria; consequently, the identification of proteins that regulate mitochondrial metabolic pathways is of great interest, and we sought to understand whether VDR may modulate these pathways. We genetically silenced VDR in HaCaT cells and studied the effects on cell growth, mitochondrial metabolism and biosynthetic pathways. VDR knockdown resulted in robust growth inhibition, with accumulation in the G0G1 phase of the cell cycle and decreased accumulation in the M phase. The effects of VDR silencing on proliferation were confirmed in several human cancer cell lines. Decreased VDR expression was consistently observed in two different models of cell differentiation. The impairment of silenced HaCaT cell growth was accompanied by sharp increases in the mitochondrial membrane potential, which sensitized the cells to oxidative stress. We found that transcription of the subunits II and IV of cytochrome c oxidase was significantly increased upon VDR silencing. Accordingly, treatment of HaCaT cells with vitamin D downregulated both subunits, suggesting that VDR may inhibit the respiratory chain and redirect TCA intermediates toward biosynthesis, thus contributing to the metabolic switch that is typical of cancer cells. In order to explore this hypothesis, we examined various acetyl-CoA-dependent biosynthetic pathways, such as the mevalonate pathway (measured as cholesterol biosynthesis and prenylation of small GTPases), and histone acetylation levels; all of these pathways were inhibited by VDR silencing. These data provide evidence of the role of VDR as a gatekeeper of mitochondrial respiratory chain activity and a facilitator of the diversion of acetyl-CoA from the energy-producing TCA cycle toward biosynthetic pathways that are essential for cellular proliferation.

Indexed as

Cell ProliferationCellular ReprogrammingElectron TransportCell Line, TumorG1 Phase Cell Cycle CheckpointsHumansMetabolic Networks and PathwaysMitochondriaM Phase Cell Cycle CheckpointsNeoplasmsReceptors, CalcitriolReceptors, Calcitriol

Identifiers

PMID25546457
PMCPMC4278832
OpenAlexW1973859913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.